PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

被引:113
作者
Martin, G [1 ]
Schoonjans, K [1 ]
Staels, B [1 ]
Auwerx, J [1 ]
机构
[1] Inst Pasteur, Dept Atherosclerose, INSERM, U325, F-59019 Lille, France
关键词
fatty acids; gene expression; lipid metabolism; nuclear receptors; peroxisomes; transcription factors;
D O I
10.1016/S0021-9150(97)00315-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is currently thought that the effects of PPAR gamma activation on glucose homeostasis may be due to the effect of this nuclear receptor on the production of adipocyte-derived signalling molecules, which affect muscle glucose metabolism. Potential signalling molecules derived from adipocytes and modified by PPAR gamma activation include TNF alpha and leptin, which both interfere with glucose homeostasis. In addition to its effects on these proteins, PPAR gamma also profoundly affects fatty acid metabolism. Activation of PPAR gamma will selectively induce the expression of several genes involved in fatty acid uptake, such as lipoprotein lipase, fatty acid transport protein and acyl-CoA synthetase, in adipose tissue without changing their expression in muscle tissue. This co-ordinate regulation of fatty acid partitioning by PPAR gamma results in an adipocyte 'FFA steal' causing a relative depletion of fatty acids in the muscle. Based on the well established interference of muscle fatty acid and glucose metabolism it is hypothesized that reversal of muscle fatty acid accumulation will contribute to the improvement in whole body glucose homeostasis. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:S75 / S80
页数:6
相关论文
共 69 条
  • [1] Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?
    Arner, P
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (02) : 89 - 94
  • [2] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [3] LIPOPROTEIN-LIPASE - RECENT CONTRIBUTIONS FROM MOLECULAR-BIOLOGY
    AUWERX, J
    LEROY, P
    SCHOONJANS, K
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) : 243 - 268
  • [4] Transcription, adipocyte differentiation, and obesity
    Auwerx, J
    Martin, G
    GuerreMillo, M
    Staels, B
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (07): : 347 - 352
  • [5] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS
    AUWERX, J
    BOUILLON, R
    COLLEN, D
    GEBOERS, J
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
  • [6] BARNETT AH, 1981, DIABETOLOGIA, V20, P600
  • [7] OPERATION OF RANDLES CYCLE IN PATIENTS WITH NIDDM
    BEVILACQUA, S
    BUZZIGOLI, G
    BONADONNA, R
    BRANDI, LS
    OLEGGINI, M
    BONI, C
    GELONI, M
    FERRANNINI, E
    [J]. DIABETES, 1990, 39 (03) : 383 - 389
  • [8] EFFECTS OF FAT ON GLUCOSE-UPTAKE AND UTILIZATION IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES
    BODEN, G
    CHEN, XH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) : 1261 - 1268
  • [9] MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE
    BODEN, G
    CHEN, XH
    RUIZ, J
    WHITE, JV
    ROSSETTI, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2438 - 2446
  • [10] EFFECTS OF FAT ON INSULIN-STIMULATED CARBOHYDRATE-METABOLISM IN NORMAL MEN
    BODEN, G
    JADALI, F
    WHITE, J
    LIANG, Y
    MOZZOLI, M
    CHEN, X
    COLEMAN, E
    SMITH, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) : 960 - 966